Proactive
16 Jan 2020
NetTargets, Inc CFO Jongho Baek sat down with Proactive at the Biotech Showcase 2020 in San Francisco. The South Korea-based company is a spin out of KAIST, one of South Korea’s top research institutes, and is an early-stage drug discovery and development firm based on AI-enhanced systems biology.
Find more information on Stocktube, where the original article was published.
We are delighted to announce that NetTargets has been named the Most Innovative Drug Discovery Company in East Asia at the Global Health and Pharma Biotechnology Awards 2023.
NetTargets will deliver a presentation at BIO KOREA 2023, to be held on 10-12 May at COEX, SEOUL (Presentation Schedule: May 11, 2023, 10:40 AM (KST)). It will also participate in partnering meetings and exhibit at the booth (no. Q25) during the conference.
